Skip to content
Home/Companies/Biotech/T-One Therapeutics

T-One Therapeutics

Biotech·Italy·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns T-One Therapeutics?

T-One Therapeutics is currently owned by Utopia SIS through Utopia SIS (2021 vintage), since 2022.

Hand-verified · updated 2026-08-02

Utopia SIS
Investor
Utopia SIS
Utopia SIS · 2021 · Life Sciences VC

Key facts

HQItaly
SectorBiotech
StatusActive

More from Utopia SIS

Other portfolio companies in the same fund.

CaSRevolution
CaSRevolution
Active
BiotechItaly· 2023
Drug Discovery and Clinic
Active
BiotechItaly· 2022
PerFormS
PerFormS
Active
BiotechItaly· 2022
Lighthouse Biotech
Active
BiotechItaly· 2021
Novavido
Active
MedTechItaly· 2021

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track T-One Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on T-One Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue